Keywords: USA, User fees, Biosimilars, Senate hearings, BIO, GPhA

BIO supports sufficient appropriations for FDA on BsUFA and PDUFA; backed by GPhA

Article | 01 April 2012

The Biotechnology Industry Organization (BIO) has expressed its support for funding of the Food and Drug Administration in its attempts ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in